title: Immune dysfunction and bacterial coinfections following influenza.
abstract: Secondary pulmonary infections by encapsulated bacteria including Streptococcus pneumoniae and Staphylococcus aureus following influenza represent a common and challenging clinical problem. The reasons for this polymicrobial synergy are still not completely understood, hampering development of effective prophylactic and therapeutic interventions. Although it has been commonly thought that viral-induced epithelial cell damage allows bacterial invasiveness, recent studies by several groups have now implicated dysfunctional innate immune defenses following influenza as the primary culprit for enhanced susceptibility to secondary bacterial infections. Understanding the immunological imbalances that are responsible for virus/bacteria synergy will ultimately allow the design of effective, broad-spectrum therapeutic approaches for prevention of enhanced susceptibility to these pathogens.
authors: Center for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA. metzged@mail.amc.edu
authors: Dennis W
authors: DW
authors: Metzger
authors: Keer
authors: K
authors: Sun
mesh_terms: D001424:Bacterial Infections / Q000150:complications* / Q000276:immunology*; D060085:Coinfection / Q000276:immunology*; D006801:Humans; D007251:Influenza, Human / Q000150:complications* / Q000276:immunology*
references: Future Microbiol. 2008 Aug;3(4):397-404
references: 18651811
references: J Immunol. 2004 Jun 15;172(12):7603-9
references: 15187140
references: Lancet Infect Dis. 2006 May;6(5):303-12
references: 16631551
references: Microbes Infect. 2011 Oct;13(11):914-22
references: 21635963
references: J Clin Invest. 2009 Jul;119(7):1910-20
references: 19487810
references: Am J Pathol. 2010 Feb;176(2):800-11
references: 20042666
references: JAMA. 2007 Oct 17;298(15):1763-71
references: 17940231
references: Nat Med. 2008 May;14(5):558-64
references: 18438414
references: Cell Res. 2012 Mar;22(3):528-38
references: 22025253
references: Immunity. 1998 Jun;8(6):683-91
references: 9655482
references: Arch Pathol Lab Med. 2010 Feb;134(2):235-43
references: 20121613
references: Emerg Infect Dis. 2012 Feb;18(2):201-7
references: 22306191
references: J Infect Dis. 1981 Sep;144(3):279-80
references: 7276637
references: J Immunol. 2003 Nov 15;171(10):5380-8
references: 14607941
references: Schweiz Med Wochenschr. 1985 Jan 19;115(3):75-86
references: 3883482
references: Trends Immunol. 2011 Jul;32(7):328-34
references: 21612981
references: J Exp Med. 2004 Jul 19;200(2):267-72
references: 15263032
references: Clin Exp Allergy. 2003 Sep;33(9):1244-51
references: 12956746
references: Infect Immun. 1983 Dec;42(3):1102-8
references: 6642660
references: Infect Dis Clin North Am. 2013 Mar;27(1):157-75
references: 23398872
references: Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L194-9
references: 16100290
references: Nat Immunol. 2008 Sep;9(9):1074-83
references: 18660812
references: J Clin Invest. 2011 Sep;121(9):3657-65
references: 21841308
references: Am Rev Respir Dis. 1986 Nov;134(5):1040-4
references: 3777666
references: Infect Immun. 2007 Mar;75(3):1196-202
references: 17210665
references: Chest. 2005 Sep;128(3):1414-22
references: 16162737
references: J Immunol. 2009 Oct 15;183(8):5301-10
references: 19783685
references: J Immunol. 2010 Feb 15;184(4):2048-56
references: 20083661
references: Blood. 1992 Nov 1;80(9):2363-73
references: 1421407
references: Br Med J. 1976 Jun 26;1(6025):1570
references: 179658
references: J Infect Dis. 1981 Jun;143(6):836-45
references: 7252265
references: Nat Med. 2009 Mar;15(3):277-84
references: 19234462
references: Nat Immunol. 2011 Nov;12(11):1045-54
references: 21946417
references: Antimicrob Agents Chemother. 2005 Jan;49(1):398-405
references: 15616320
references: J Immunol. 2008 Feb 15;180(4):2562-72
references: 18250467
references: J Immunol. 2013 Aug 1;191(3):1250-9
references: 23804714
references: Biochem Soc Trans. 2009 Aug;37(Pt 4):811-3
references: 19614599
references: J Exp Med. 2008 Feb 18;205(2):323-9
references: 18227219
references: J Virol. 2010 May;84(10):5007-14
references: 20200252
references: J Immunol. 2010 Apr 1;184(7):3755-67
references: 20176744
references: J Immunol. 2011 Jan 15;186(2):987-93
references: 21160043
references: Chest. 2005 Dec;128(6):3854-62
references: 16354854
references: J Virol. 2012 Apr;86(7):3564-73
references: 22278240
references: J Immunol. 2011 Feb 1;186(3):1666-1674
references: 21178015
references: Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S69-74
references: 21342902
references: J Exp Med. 1989 Aug 1;170(2):499-509
references: 2526847
references: mBio. 2011 Sep 20;2(5):
references: 21933918
references: J Infect Dis. 2010 Feb 15;201(4):508-15
references: 20078212
references: Infect Immun. 1990 Sep;58(9):2809-14
references: 2143751
references: Science. 2008 Jul 18;321(5887):356-61
references: 18635788
references: J Clin Invest. 1976 Jun;57(6):1533-9
references: 180054
references: Infect Immun. 2006 Dec;74(12):6707-21
references: 16982840
references: J Infect Dis. 2009 Feb 1;199(3):311-9
references: 19113989
references: MMWR Morb Mortal Wkly Rep. 2009 Sep 4;58(34):941-7
references: 19730406
references: Am Rev Respir Dis. 1977 Feb;115(2):269-77
references: 842940
references: J Infect Dis. 2006 Jan 15;193(2):214-22
references: 16362885
references: Infect Immun. 1979 Nov;26(2):651-7
references: 546791
references: Infect Immun. 1980 Mar;27(3):960-8
references: 6247283
references: J Immunol. 2009 Jun 15;182(12):7353-63
references: 19494257
references: J Immunol. 2009 Aug 1;183(3):1990-6
references: 19587022
references: Cell Host Microbe. 2007 Oct 11;2(4):240-9
references: 18005742
references: J Virol. 2013 Jun;87(12):6911-24
references: 23596287
references: Vaccine. 2008 Sep 12;26 Suppl 4:D59-66
references: 19230162
references: J Infect Dis. 2003 Mar 15;187(6):1000-9
references: 12660947
references: Lancet. 1958 Nov 29;2(7057):1141-3
references: 13612141
references: J Clin Invest. 1959 Jan;38(1 Part 2):213-65
references: 13620784
references: Clin Microbiol Rev. 2006 Jul;19(3):571-82
references: 16847087
references: Microbiol Immunol. 2011 Nov;55(11):751-9
references: 21895747
references: Scand J Infect Dis. 2008;40(1):11-7
references: 17852951
references: J Virol Methods. 2001 May;94(1-2):173-86
references: 11337052
references: J Virol. 2010 Apr;84(8):4105-8
references: 20130054
references: PLoS Pathog. 2011 Feb;7(2):e1001304
references: 21383977
references: J Infect Dis. 2008 Oct 1;198(7):962-70
references: 18710327
references: J Infect Dis. 2002 Aug 1;186(3):341-50
references: 12134230
references: J Virol. 2012 Nov;86(22):12304-12
references: 22951826